SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
Zanubrutinib May Lead to Cost Savings vs Ibrutinib in R/R CLL
Significant Disease Burden and Management Issues in Chronic Spontaneous Urticaria
Lifestyle Interventions, Statins, Among Keys to Mitigating CVD Risk in MASLD/MASH
2 Commerce Drive
Cranbury, NJ 08512